PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

Eversept Partners, LP's Holding History (CIK: 0001697013)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 52,961 Value ($000) $4,626 Avg Close $81.85 Range $62.24 - $96.54
Q2 2025
Shares 277,316 Value ($000) $15,327 Avg Close $47.99 Range $39.60 - $57.70
Q1 2025
Shares 547,116 Value ($000) $26,459 Avg Close $41.90 Range $33.70 - $60.60
Q4 2024
Shares 678,787 Value ($000) $26,201 Avg Close $43.60 Range $33.31 - $48.89
Q3 2024
Shares 445,204 Value ($000) $20,034 Avg Close $40.40 Range $32.50 - $48.00
Q2 2024
Shares 505,836 Value ($000) $17,527 Avg Close $29.29 Range $24.22 - $35.96
Q1 2024
Shares 411,478 Value ($000) $11,904 Avg Close $27.21 Range $21.43 - $33.34
Q4 2023
Shares 538,074 Value ($000) $12,338 Avg Close $17.50 Range $13.72 - $23.88
Q3 2023
Shares 286,748 Value ($000) $4,783 Avg Close $19.40 Range $16.33 - $26.81
Q2 2023
Shares 114,659 Value ($000) $3,167 Avg Close $25.03 Range $17.64 - $30.10